Evidence map›Paper›PMID 37632261›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2023

Progressive reduction in basal ganglia explains and predicts cerebral structural alteration in type 2 diabetes.

Kyu Sung Choi, Inpyeong Hwang, Joon Ho Moon, Minchul Kim

Open access · hybridAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kyu Sung ChoiDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.
Inpyeong HwangDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.
Joon Ho MoonDivison of Endocrinology & Metabolism, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Minchul KimDepartment of Radiology, Kangnam Sacred Heart Hospital, Hallym University School of Medicine, Seoul, Korea.ORCID 0000-0002-4614-1146
Seoul National University Hospital · KRHallym University · KRSeoul National University Bundang Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes is consistently reported to be associated with reduced gray matter, mainly in the cortical-striatal-limbic networks. However, little is known about how the progression of diabetes affects cerebral gray matter. To investigate, we collected 543 age- and sex-matched participants of nondiabetes, prediabetes, and diabetes. Voxel-based morphometry using a linear trend model was performed to reveal brain regions associated with disease progression. The Granger causal network of structural covariance was used to assess the causal relationships of brain structural alterations according to disease progression. Multivariate pattern analysis was applied for the stage-specific predictions of hyperglycemia. We detected a linear trend of gray matter volume reduction in the basal ganglia with disease progression (P < 0.05, FWER corrected), which caused a reduction in bilateral temporal gyri, frontal pole, parahippocampus, and bilateral posterior cingulate/precuneus volumes. In addition, the gray matter pattern of the basal ganglia could predict patients with diabetes (accuracy 60.12%,

Indexed as

Diabetes Mellitus, Type 2Basal GangliaBrainDisease ProgressionGray MatterHumansMagnetic Resonance Imagingbasal gangliacausal covariance networkmultivoxel pattern approachstructural MRIType 2 diabetes

Identifiers

PMID37632261
PMCPMC10925861
OpenAlexW4386188114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.